Device
0.1% sodium hyaluronate
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_4
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Other(2)
Detailed Status
unknown2
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 41 (33.3%)
N/A2 (66.7%)
Trials by Status
not_yet_recruiting133%
unknown267%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable
Effect of Artificial Tears on Ocular Biometry Parameters
NCT06656403
unknownphase_4
Topical Bromfenac for Intraoperative Miosis and Pain Reduction
NCT03831984
unknownnot_applicable
Correlation of Noninvasive Tear Film Function and the Optical Quality in Mild and Moderate Dry Eye
NCT03815539
Clinical Trials (3)
Showing 3 of 3 trials
NCT06656403Not Applicable
Effect of Artificial Tears on Ocular Biometry Parameters
NCT03831984Phase 4
Topical Bromfenac for Intraoperative Miosis and Pain Reduction
NCT03815539Not Applicable
Correlation of Noninvasive Tear Film Function and the Optical Quality in Mild and Moderate Dry Eye
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3